Integrated Therapy Development Services for Psychiatric Disorders

Integrated Therapy Development Services for Psychiatric Disorders

Inquiry

Ace Therapeutics is your ideal partner for research and development of therapies for psychiatric disorders. We are a preclinical contract research organization focused on psychiatric disorders with expertise in behavioral neuroscience, neuroimaging, and psychopharmacology. Our comprehensive services and support are designed to help you break through the limitations of traditional therapies and develop more effective and innovative treatments for psychiatric disorders.

Different therapies for psychiatric disorders.

Integrated Therapy Development Services for Psychiatric Disorders We Offered

The standard first-line treatments for psychiatric disorders include medications and cognitive behavioral therapy. However, the high incidence of treatment resistance and failure has sparked interest in other novel therapies. Ace Therapeutics applies our expertise in behavioral neuroscience, neuroimaging, and psychopharmacology to help clients provide comprehensive services and support in the development of therapies that will advance the field of innovative treatments.

Small Molecule Antipsychotic Development Services

Ace Therapeutics offers a comprehensive suite of solutions, spanning drug discovery and preclinical development across a diverse range of drug types and key services. Our expertise and platform technologies enable us to assist clients in the development of innovative small molecule antipsychotics. We provide comprehensive evaluation of preclinical efficacy, safety, and pharmacokinetic properties of potential drug candidates, including neurotransmitter drugs, neuroimmune drugs, and psychedelic drugs.

Therapeutic Biologics Development Services for Psychiatric Disorders

Therapeutic biologics for psychiatric disorders encompass a diverse range of drug types, including protein-based antipsychotics, nucleic acid-based antipsychotics, cell/gene therapy-based antipsychotics, and microbiome-based antipsychotics. These distinct biotherapeutics employ varying mechanisms and have diverse potential applications in the treatment of psychiatric disorders.

Ace Therapeutics is dedicated to providing comprehensive support throughout the drug discovery, preclinical screening, efficacy, and safety evaluation stages, enabling clients to expedite their innovative drug development process.

Preclinical Electroconvulsive Therapy Development Services

Ace Therapeutics offers comprehensive preclinical electroconvulsive therapy development services to our clients. Our Services focuses on the following areas: neurophysiological mechanisms of psychiatric disorders, mechanisms of action of electroconvulsive therapy, optimization of electroconvulsive therapy parameters, and preclinical evaluation of electroconvulsive therapy. Our objective is to assist our clients in developing safer and more effective electroconvulsive therapies, thereby providing enhanced treatment options for patients with psychiatric disorders.

Preclinical Noninvasive Brain Stimulation Development Services

Deep brain stimulation is a promising therapeutic paradigm that has the potential to modulate the abnormal pathways and networks associated with mental illness states. Ace Therapeutics helps clients optimize stimulation sites, stimulation parameters, and treatment regimens by delving into the pathology of psychiatric disorders and the mechanisms of action of noninvasive brain stimulation. In addition, we utilize customized in vivo models to comprehensively evaluate the efficacy and safety of new therapies to support the clinical application of NIBS in psychiatric disorders.

Preclinical Hyperbaric Oxygen Therapy Development Services

Ace Therapeutics scientists provide theoretical support for the development of novel hyperbaric oxygen therapies by thoroughly exploring the mechanisms of action of hyperbaric oxygen therapy in psychiatric disorders. Our understanding of these mechanisms allows us to assist our clients in optimizing the therapeutic parameters and regimens of hyperbaric oxygen therapy, as well as in fully evaluating the efficacy and safety of these therapies.

Our Capabilities and Advantages

  • An interdisciplinary team of professionals offers customized, integrated therapy development services to accelerate your psychiatric disorders therapy development program.
  • Validated animal models and extensive behavioral analyses support you in conducting mechanistic researches, efficacy and safety assessments of different psychiatric therapies.
  • Advanced neuroimaging, electrophysiology, molecular biology, and high-throughput screening technologies provide you with accurate and reliable results and data support.
  • Ethical and safety issues are given high priority and international standards and guidelines are followed.

Ace Therapeutics provides comprehensive services and support to help clients make breakthroughs in scientific research and therapy development in different areas of psychiatric disorders. Contact us for more details and collaboration. We will be happy to assist you.


Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright Ā© Ace Therapeutics. All Rights Reserved.
Top